Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.

Industry: Pharmaceutical Preparations Peers: Kallo Inc.